Complete pathological and serological response to immunotherapy in a patient with MMR-deficient early rectal cancer

L. S. Tarpgaard; P. V. Andersen; N. Øgaard; C. Demuth; C. L. Andersen; P. Pfeiffer

doi:10.1016/j.annonc.2021.03.001

Complete pathological and serological response to immunotherapy in a patient with MMR-deficient early rectal cancer

L. S. Tarpgaard, P. V. Andersen, N. Øgaard, C. Demuth, C. L. Andersen, P. Pfeiffer

Research output: Contribution to journal › Comment/debate › Research › peer-review

Original language	English
Journal	Annals of Oncology
Volume	32
Issue number	6
Pages (from-to)	805-806
ISSN	0923-7534
DOIs	https://doi.org/10.1016/j.annonc.2021.03.001
Publication status	Published - Jun 2021

Keywords

Humans
Immunotherapy
Rectal Neoplasms/therapy

Documents & Links

10.1016/j.annonc.2021.03.001

Cite this

@article{f3405c301c284895a2e4ace5def81d71,

title = "Complete pathological and serological response to immunotherapy in a patient with MMR-deficient early rectal cancer",

keywords = "Humans, Immunotherapy, Rectal Neoplasms/therapy",

author = "Tarpgaard, {L. S.} and Andersen, {P. V.} and N. {\O}gaard and C. Demuth and Andersen, {C. L.} and P. Pfeiffer",

note = "Funding Information: This work was supported by The Danish Cancer Society [grant numbers R231-A13845 , R257-A14700 ], The NEYE foundation and The Novo Nordisk Foundation [grant number NNF17OC0025052 ]. ",

year = "2021",

month = jun,

doi = "10.1016/j.annonc.2021.03.001",

language = "English",

volume = "32",

pages = "805--806",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Complete pathological and serological response to immunotherapy in a patient with MMR-deficient early rectal cancer

AU - Tarpgaard, L. S.

AU - Andersen, P. V.

AU - Øgaard, N.

AU - Demuth, C.

AU - Andersen, C. L.

AU - Pfeiffer, P.

N1 - Funding Information: This work was supported by The Danish Cancer Society [grant numbers R231-A13845 , R257-A14700 ], The NEYE foundation and The Novo Nordisk Foundation [grant number NNF17OC0025052 ].

PY - 2021/6

Y1 - 2021/6

KW - Humans

KW - Immunotherapy

KW - Rectal Neoplasms/therapy

U2 - 10.1016/j.annonc.2021.03.001

DO - 10.1016/j.annonc.2021.03.001

M3 - Comment/debate

C2 - 33727198

AN - SCOPUS:85104952510

SN - 0923-7534

VL - 32

SP - 805

EP - 806

JO - Annals of Oncology

JF - Annals of Oncology

IS - 6

ER -